نتائج البحث - "Halilovic, Ensar"

1

دورية أكاديمية

BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics.

المؤلفون: Pan, Rongqing, Wang, Youzhen, Qiu, Shumei, Villalobos-Ortiz, Mariana, Ryan, Jeremy, Erick, Morris, Halilovic, Ensar, Letai, Anthony

العلاقة: Pan, Rongqing, Wang, Youzhen, Qiu, Shumei, Villalobos-Ortiz, Mariana, Ryan, Jeremy, Erick, Morris, Halilovic, Ensar and Letai, Anthony (2024) BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics. Haematologica, 109 (4). pp. 1253-1258. ISSN 1592-8721

الإتاحة: https://doi.org/10.3324/haematol.2023.283060Test
https://oak.novartis.com/48272Test/
https://haematologica.org/article/view/haematol.2023.283060Test

View record in BASE

2

دورية أكاديمية

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

المساهمون: MS Medische Oncologie, Cancer, Externen Med. Onco, MS Hematologie, Infection & Immunity

مصطلحات موضوعية: Oncology, Cancer Research, Journal Article

وصف الملف: application/pdf

العلاقة: https://dspace.library.uu.nl/handle/1874/444547Test

الإتاحة: https://dspace.library.uu.nl/handle/1874/444547Test

View record in BASE

النص الكامل

3

دورية أكاديمية

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

المؤلفون: Townsend, Elizabeth C, Murakami, Mark A, Christodoulou, Alexandra, Christie, Amanda L, Köster, Johannes, DeSouza, Tiffany A, Morgan, Elizabeth A, Kallgren, Scott P, Liu, Huiyun, Wu, Shuo-Chieh, Plana, Olivia, Montero, Joan, Stevenson, Kristen E, Rao, Prakash, Vadhi, Raga, Andreeff, Michael, Armand, Philippe, Ballen, Karen K, Barzaghi-Rinaudo, Patrizia, Cahill, Sarah, Clark, Rachael A, Cooke, Vesselina G, Davids, Matthew S, DeAngelo, Daniel J, Dorfman, David M, Eaton, Hilary, Ebert, Benjamin L, Etchin, Julia, Firestone, Brant, Fisher, David C, Freedman, Arnold S, Galinsky, Ilene A, Gao, Hui, Garcia, Jacqueline S, Garnache-Ottou, Francine, Graubert, Timothy A, Gutierrez, Alejandro, Halilovic, Ensar, Harris, Marian H, Herbert, Zachary T, Horwitz, Steven M, Inghirami, Giorgio, Intlekofer, Andrew M, Ito, Moriko, Izraeli, Shai, Jacobsen, Eric D, Jacobson, Caron A, Jeay, Sébastien, Jeremias, Irmela, Kelliher, Michelle A, Koch, Raphael, Konopleva, Marina, Kopp, Nadja, Kornblau, Steven M, Kung, Andrew L, Kupper, Thomas S, LeBoeuf, Nicole R, LaCasce, Ann S, Lees, Emma, Li, Loretta S, Look, A Thomas, Murakami, Masato, Muschen, Markus, Neuberg, Donna, Ng, Samuel Y, Odejide, Oreofe O, Orkin, Stuart H, Paquette, Rachel R, Place, Andrew E, Roderick, Justine E, Ryan, Jeremy A, Sallan, Stephen E, Shoji, Brent, Silverman, Lewis B, Soiffer, Robert J, Steensma, David P, Stegmaier, Kimberly, Stone, Richard M, Tamburini, Jerome, Thorner, Aaron R, van Hummelen, Paul, Wadleigh, Martha, Wiesmann, Marion, Weng, Andrew P, Wuerthner, Jens U, Williams, David A, Wollison, Bruce M, Lane, Andrew A, Letai, Anthony, Bertagnolli, Monica M, Ritz, Jerome, Brown, Myles, Long, Henry, Aster, Jon C, Shipp, Margaret A, Griffin, James D, Weinstock, David M

المصدر: Cancer Cell. 29(4)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Biotechnology, Clinical Trials and Supportive Activities, Orphan Drug, Clinical Research, Hematology, Cancer, Rare Diseases, 5.1 Pharmaceuticals, Development of treatments and therapeutic interventions, Good Health and Well Being, Animals, Antineoplastic Agents, Biomarkers, Tumor, Cell Lineage, Female, Gene Expression Profiling, Genes, p53, Heterografts, Humans, Internet, Isoquinolines, Leukemia, Leukemia, Experimental, Lymphoma, Male, Mice, Mice, Inbred NOD, Molecular Targeted Therapy, Neoplasm Proteins, Neoplasm Transplantation, Phenotype, Piperazines, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Proteome, Proto-Oncogene Proteins c-mdm2, Random Allocation, Randomized Controlled Trials as Topic, Research Design, Tissue Banks, Transcriptome, Xenograft Model Antitumor Assays, Neurosciences, Oncology & Carcinogenesis, Biochemistry and cell biology, Oncology and carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/2s38q1mgTest

View record in eScholarship

4

دورية أكاديمية

Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies

المؤلفون: Bauer, Sebastian, Demetri, George D, Halilovic, Ensar, Dummer, Reinhard, Meille, Christophe, Tan, Daniel S W, Guerreiro, Nelson, Jullion, Astrid, Ferretti, Stephane, Jeay, Sébastien, van Bree, Laurence, Hourcade-Potelleret, Florence, Wuerthner, Jens U, Fabre, Claire, Cassier, Philippe A

المصدر: Bauer, Sebastian; Demetri, George D; Halilovic, Ensar; Dummer, Reinhard; Meille, Christophe; Tan, Daniel S W; Guerreiro, Nelson; Jullion, Astrid; Ferretti, Stephane; Jeay, Sébastien; van Bree, Laurence; Hourcade-Potelleret, Florence; Wuerthner, Jens U; Fabre, Claire; Cassier, Philippe A (2021). Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies. British Journal of Cancer, 125(5):687-698.

مصطلحات موضوعية: Dermatology Clinic, 610 Medicine & health, Cancer Research, Oncology

وصف الملف: application/pdf

العلاقة: https://www.zora.uzh.ch/id/eprint/209201/1/918_Bauer_S._et_al._Pharmacokinetic-pharmacodynamic_guided_optimisation_of_dose_and_schedule_of_CGM097,_an_HDM2_inhibitor_Br_J_Cancer_2021.pdfTest; info:pmid/34140638; urn:issn:0007-0920

الإتاحة: https://doi.org/10.5167/uzh-20920110.1038/s41416-021-01444-4Test
https://www.zora.uzh.ch/id/eprint/209201Test/
https://www.zora.uzh.ch/id/eprint/209201/1/918_Bauer_S._et_al._Pharmacokinetic-pharmacodynamic_guided_optimisation_of_dose_and_schedule_of_CGM097,_an_HDM2_inhibitor_Br_J_Cancer_2021.pdfTest

View record in BASE

النص الكامل

5

دورية أكاديمية

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

وصف الملف: application/pdf

العلاقة: Clinical Cancer Research; Vol. 28 (december 2021), p. 870-881; https://ddd.uab.cat/record/280553Test; urn:10.1158/1078-0432.CCR-21-1295; urn:oai:ddd.uab.cat:280553; urn:pmcid:PMC9377734; urn:pmc-uid:9377734; urn:pmid:34862243; urn:oai:pubmedcentral.nih.gov:9377734; urn:articleid:15573265v28p870

الإتاحة: https://ddd.uab.cat/record/280553Test

View record in BASE

النص الكامل

6

دورية أكاديمية

Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma

المساهمون: Universidad de Cantabria

المصدر: Haematologica . 2020 Mar;105(3):e116-e120

العلاقة: https://doi.org/10.3324/haematol.2018.212308Test; http://hdl.handle.net/10902/21479Test

الإتاحة: https://doi.org/10.3324/haematol.2018.212308Test
http://hdl.handle.net/10902/21479Test

View record in BASE

النص الكامل

7

دورية أكاديمية

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer

المؤلفون: Portman, Neil, Milioli, Heloisa H., Alexandrou, Sarah, Coulson, Rhiannon, Yong, Aliza, Fernandez, Kristine J., Chia, Kee Ming, Halilovic, Ensar, Segara, Davendra, Parker, Andrew, Haupt, Sue, Haupt, Ygal, Tilley, Wayne D., Swarbrick, Alex, Caldon, C. Elizabeth, Lim, Elgene

المساهمون: National Breast Cancer Foundation, Cancer Institute NSW, Breast Cancer Trials - Australia and New Zealand, The Estate of the Late RT Hall, Love Your Sister

المصدر: Breast Cancer Research ; volume 22, issue 1 ; ISSN 1465-542X

الإتاحة: https://doi.org/10.1186/s13058-020-01318-2Test

View record in BASE